INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Why Settle For Good Enough On The "Easy" Stuff?
High-stakes expertise shouldn’t be reserved for complex trials. Applying strategic support early helps prevent inefficiencies, delays, and missed opportunities.
-
The Role Of Company Culture In FSP Partnerships
This piece explores intentional culture-building as a strategic asset in FSP engagements, transforming transactional relationships into enduring, high-performing partnerships.
-
New Purpose-Built Facility For Large-Scale Sterile Fill/Finish Operations
Expanding capacity for late-phase clinical and large-scale commercial small molecule and biologic drugs, a new facility boosts sterile fill/finish capabilities.
-
Optimizing Site Activation To Accelerate Clinical Trials
Clinical trial site activation delays are a major bottleneck in drug development, hampering trial timelines and funding flows. To reverse this trend, site-focused solutions are being prioritized.
-
Overcoming Unexpected Obstacles In A Phase 1 Study1/29/2025
Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.
-
Price Matters - Why Dash Believes In Transparency5/15/2026
Opaque pricing slows decisions and erodes trust. Transparency clarifies cost drivers, improves budgeting, enables confident sourcing, and strengthens long-term R&D partnerships.
-
Enhancing Participant Payments: A New Approach10/30/2024
Managing participant payments in clinical trials is a multifaceted challenge impacting participants, sites, and sponsors alike. Delve into the intricacies and numerous hurdles faced in this process.
-
Launching A Unified Global Sales Team In 90 Days11/7/2025
A global CRO united 300+ sales and executive leaders across five continents for a dynamic, space-themed meeting that strengthened culture, deepened product understanding, and inspired alignment toward annual growth goals.
-
Optimizing Clinical Supply Flexibility With Demand-Led Strategies3/24/2026
Explore demand-led supply strategies for clinical trials. Compare traditional vs. DLS models and learn when pack-to-order, pack-to-stock, or hybrid approaches optimize supply flexibility.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Accelerate your cell or gene therapeutic to market with tailored clinical and regulatory strategies and expert insights.
-
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
-
For successful regulatory outcomes, we provide quality medical writing services for clinical trial documents, safety updates, and marketing applications.
-
Accelerator™ Drug Development provides a strategic, end-to-end partnership model that helps sponsors optimize resources, overcome development challenges, and advance promising therapies.
-
Our site payments portal provides complete transparency, allowing you to fully outsource your payment operations to our experts or adopt a customizable hybrid model.